CONMED Corporation

CONMED Corporation

CNMDยทNYSE

$33.06

-2.3%
HealthcareMedical - Devices

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

At a Glance

Live Snapshot
Market Cap$995.41M
EPS1.5200
P/E Ratio21.75
Earnings Date07/29/2026
3Y+412.0%
5Y+165.0%
10Y+347.0%
3Y-92.0%
5Y+54.0%
10Y-92.0%
3Y-160.0%
5Y+161.0%
10Y-174.0%
CNMD

CONMED Corporation Cash Conversion Engine

CNMD ยท NYSE
Net Income47.05M
Depreciation & Amortization74.28M
Stock-Based Compensation28.32M
Change in Working Capital-11.45M
Others28.96M
Capital Expenditures-19.81M
Free Cash Flow150.88M

Cash Flow Quality Analysis

FCF Conversion Rate

320.7%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

11.6%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

-2.0%

Flat FCF growth. Stable but not expandingโ€”monitor for signs of business maturity or temporary headwinds.

Working Capital Impact

-$11.45M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.

CONMED Corporation Cash Flow Statement

CNMD โ€ข NYSE

CONMED Corporation Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
OPERATING ACTIVITIES
47.1M
132.4M
64.5M
-80.6M
62.5M
9.5M
28.6M
40.9M
55.5M
14.7M
30.5M
32.2M
35.9M
40.5M
752K
30.3M
12.1M
44.6M
41.5M
-12.5M
74.3M
51.3M
51.4M
69.5M
70.7M
72.6M
72.3M
61.8M
58.5M
55.3M
43.9M
45.7M
47.9M
46.6M
42.7M
41.8M
41.3M
32.3M
31.5M
29.9M
3.5M
12.2M
700K
-6M
3M
-14.2M
-6.3M
2.1M
-40M
-2.9M
2.3M
-284K
7.2M
12.9M
-13.1M
13.2M
4.2M
19M
16.7M
-12.3M
28.3M
25.6M
24.3M
21.7M
16.3M
13.1M
11.8M
10M
8.5M
8.4M
7.5M
9.3M
5.6M
5.7M
5.2M
4.2M
4.3M
4.2M
0.0
0.0
29M
-14.8M
24.1M
119.4M
14.8M
13.4M
12.4M
4.2M
143.4M
118.3M
12.3M
1.3M
263K
8.1M
60.3M
-28.9M
-14.1M
-12.9M
3.8M
50.6M
(0.0)
(15.2M)
(19.9M)
(9.1M)
(8.6M)
(9.1M)
(10.6M)
(11M)
(8.9M)
(9.6M)
(10.3M)
(10.2M)
(6.8M)
(11M)
(4.8M)
(3.3M)
(3.7M)
(7.4M)
(0.0)
(0.0)
-11.5M
-39.7M
-39.6M
-90.7M
-55.7M
-29.9M
-23.6M
-44.3M
-16.9M
-37.3M
-36.1M
-21.8M
-15.9M
-10.5M
7.1M
-22.4M
-22.9M
-26M
-22.5M
7M
170.7M
167M
125.3M
33.4M
111.8M
64.5M
95.1M
74.7M
65.6M
38.2M
48.1M
65.2M
80.9M
95.2M
103M
38.2M
25M
61.1M
65.9M
64.6M
INVESTING ACTIVITIES
-19.8M
-13.1M
-19M
-21.8M
-14.9M
-13M
-20.1M
-16.5M
-12.8M
-14.8M
-15M
-15.4M
-18.4M
-21.5M
-21.7M
-14.7M
-21.4M
-35.9M
-20.9M
-21.9M
(0.0)
(0.0)
(0.0)
-227.7M
(0.0)
-3.9M
-367.6M
(0.0)
-16.2M
-256.5M
-9.4M
-5.3M
(0.0)
-86.3M
-4.2M
-5.3M
-330K
-22M
-5.9M
-2.5M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2M
-1.2M
0.0
-1M
0.0
0.0
3.2M
0.0
0.0
0.0
5.2M
0.0
0.0
0.0
1.8M
4.2M
0.0
0.0
0.0
0.0
0.0
-21M
-13.1M
-20M
-249.5M
-14.9M
-13.6M
-387.7M
-16.5M
-29.1M
-266M
-24.4M
-20.7M
-18.4M
-105.9M
-21.7M
-20M
-21.8M
-57.9M
-26.8M
-23.2M
FINANCING ACTIVITIES
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-16.9M
-50.6M
-3.9M
-15M
-23M
1.2M
7.3M
11.4M
-5.1M
-74.6M
-72M
-88M
362M
-81.2M
-29.4M
362.9M
-29.7M
-12.2M
227.6M
29.4M
25.9M
53.7M
18.3M
-56M
6.9M
-5.8M
-14.4M
-45M
-39M
-24.7M
-24.7M
-24.5M
-24M
-23.3M
-22.8M
-22.6M
-22.4M
-22.3M
-22.2M
-22.1M
-22M
-16.7M
-12.9M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-72M
(0.0)
(0.0)
-30.6M
(0.0)
(0.0)
(0.0)
(0.0)
-16.9M
-50.6M
-3.9M
-15M
-23M
(0.0)
(0.0)
(0.0)
-7.8M
-36.5M
-54.3M
2.1M
-113.1M
3M
162K
-39.4M
-20.1M
-372K
-22.8M
-17.1M
-13.4M
-17.8M
9.8M
4.3M
478K
886K
1.7M
-1.8M
45K
-135.8M
-151M
-110.4M
225M
-101.5M
-52.1M
300.9M
-72.3M
-34.9M
184.2M
-9.8M
-26.4M
-31.3M
11.4M
-66.7M
-15.6M
-4.6M
-5.4M
-35.4M
-44.1M
CASH FLOW SUMMARY
2.4M
-2.7M
470K
-741K
-1.9M
2.7M
-7K
-1M
3.6M
-1.5M
-7.8M
-6.2M
-485K
-2.9M
-920K
-297K
-1.3M
2.2M
4.2M
3.1M
16.4M
163K
-4.6M
8.1M
-6.5M
1.5M
8.3M
-15.1M
5.2M
-45.1M
6.2M
11.9M
30.7M
-2.3M
13.6M
2.3M
-2.6M
116K
7.9M
377K
24.5M
24.3M
28.9M
20.8M
27.4M
25.9M
17.5M
32.6M
27.4M
72.5M
66.3M
54.4M
23.7M
26M
12.4M
10.1M
11.8M
11.7M
3.8M
3.5M
40.8M
24.5M
24.3M
28.9M
20.8M
27.4M
25.9M
17.5M
32.6M
27.4M
72.5M
66.3M
54.4M
23.7M
26M
12.4M
9.2M
11.8M
11.7M
3.8M
150.9M
153.9M
106.3M
11.6M
96.9M
51.5M
75.1M
58.2M
52.7M
23.5M
33.1M
49.8M
62.5M
73.7M
81.3M
23.5M
3.6M
25.3M
45M
42.7M

SEC Filings

CNMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

June 01, 2026
May 27, 2026
2026
8-K

8-K 2026

N/A

May 20, 2026
May 18, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 30, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 29, 2026
April 29, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 07, 2026
May 18, 2026
2026
8-K

8-K 2026

N/A

March 13, 2026
March 13, 2026
2026
10-K

10-K 2025 FY

FY

February 17, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 28, 2026
January 28, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 12, 2026
2026
8-K

8-K 2026

N/A

January 08, 2026
January 06, 2026
2026
Showing 1 to 10 of 434 filings